Suneel Gupta Protagonist Therapeutics, Inc (PTGX) insider trading activity
Suneel Gupta is Chief Development Officer of Protagonist Therapeutics, Inc. Currently has a direct ownership of 183,285 shares of PTGX, which is worth approximately $7.7 Million. The most recent transaction as insider was on Feb 26, 2024, when has been sold 4,282 shares (Common Stock) at a price of $29.53 per share, resulting in proceeds of $126,447. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
183K
0%
3M change
23.81%
12M change
Total Value Held
$7.7 Million
Suneel Gupta Transaction History
SG
Suneel Gupta
Chief Development Officer
Newark, CA